1. The basic situation of the meeting
(1) Number of shareholders meeting
This meeting is the second extraordinary general meeting of shareholders in 2021.

(2) Convener
The convener of this general meeting of shareholders is the board of directors.
none

(3) The legality and compliance of the meeting
The convening and time, method, convener and moderator of this general meeting of shareholders are in compliance with the "Company Law of the People's Republic of China", "Articles of Association of Shanghai Yan'an Pharmaceutical Yangpu Co., Ltd." and "Rules of Procedures for the General Meeting of Shareholders" and other relevant laws and regulations Regulation.

(4) Method of convening the meeting
The meeting was held by on-site voting.
none

(5) Date and time of the meeting
1. On-site meeting time: 13:30, September 15, 2021.
none

(6) Attendance
1. Shareholders who hold the company's shares on the date of equity registration.
All shareholders of the company registered with ChinaClear at the end of the afternoon on the equity registration day (see the table below for details) are entitled to attend the general meeting (investors who bought securities on the equity registration day have this right, and sold on the equity registration day Securities investors do not have this right), shareholders can appoint an agent in writing to attend the meeting and vote, and the shareholder agent does not have to be a shareholder of the company. Among them, it does not include preference shareholders, and does not include preference shareholders whose voting rights have been restored.

2. Directors, supervisors, senior managers and persons in charge of information disclosure affairs of the company.
(7) Meeting place
VIP Conference Room, 15th Floor, Block C, Lane 58, Xinjian East Road, Minhang District, Shanghai

2. Matters considered at the meeting
(1) Reviewing the "Proposal on the Company's Proposal to Terminate the Continuous Supervision Agreement with Guotai Junan Securities Co., Ltd."
Based on the company's development needs, the company plans to terminate the continuous supervision agreement after full communication and friendly negotiation with Guotai Junan Securities Co., Ltd. and reach an agreement on termination related matters. Guotai Junan Securities Co., Ltd. will no longer serve as the company's continuous supervision of the main brokerage firm after this change has been approved by the National SME Share Transfer System.

(2) Reviewing the "Proposal on the Explanatory Report on the Termination of the Continuous Supervision Agreement with Guotai Junan Securities Co., Ltd."
In accordance with relevant regulations such as the "Guidelines for the Consultation of the Leading Securities Dealers and Listed Companies in the National SME Share Transfer System to Resolve the Continuous Supervision Agreement" The transfer system submitted the "Explanatory Report on the Termination of the Continuous Supervision Agreement with Guotai Junan Securities Co., Ltd.".

(3) Reviewing the "Proposal on the Company's Proposal to Sign a Continuous Supervision Agreement with Tianfeng Securities Co., Ltd."
Based on the company's development needs, and in accordance with the relevant requirements and regulations of the China Securities Regulatory Commission and the National SME Share Transfer System, the company plans to sign the "Continuing Supervision Agreement" with Tianfeng Securities Co., Ltd. After this continuous supervision of the change of the main brokerage firm is reviewed and approved by the National SME Share Transfer System, Tianfeng Securities Co., Ltd. will take over the main brokerage firm and perform its continuous supervision obligations.

(4) Deliberating the "Proposal on Authorizing the Board of Directors with Full Power to Handle Matters Concerning the Continuous Supervision of the Change of the Leading Securities Dealer"
In order to ensure the company's successful completion of this continuous supervision of the host brokerage change, it is proposed to authorize the company's board of directors to be fully responsible for the company's continuous supervision of the host brokerage change. The specific scope of authorization includes the declaration of relevant documents and information to the National SME Share Transfer System Company for the continuous supervision of the host brokerage change, approval and signing of the documents and contracts related to the continuous supervision of the host brokerage change, and the handling of the continuous supervision of the host brokerage company. All other matters related to the change.

There is no special resolution for the above proposal;
There is no cumulative voting proposal for the above proposal;
There is no separate vote counting proposal for small and medium investors in the above proposal;
There is no resolution of related shareholders' withdrawal form for the above-mentioned proposal;
There is no proposal in which preferred shareholders participate in voting on the above proposal.
There is no proposal to review the public offering of stocks and list them on the selection layer.
3. Conference registration method
(1) Registration method
Shareholders attending the meeting shall register with the following documents: natural person shareholders shall hold their own ID cards; if an agent represents individual shareholders to attend this meeting, they shall present the ID card (copy) of the entrusting person and the authorized entrustment signed by the entrusting person The legal person shareholder shall present his ID card and the legal representative’s identity certificate when attending this meeting; if the legal person shareholder entrusts a representative to attend this meeting, he shall present his ID card and stamp The official seal of the unit and a written power of attorney signed by the legal representative; shareholders can register by letter, fax and door-to-door registration. The company does not accept registration by telephone.

(2) Registration time: 9:30 to 10:30 on September 15, 2021

(3) Place of registration: VIP meeting room on the 15th floor, Block C, Lane 58, Xinjian East Road, Minhang District, Shanghai

Four, other
(1) Conference contact information: 1. Contact address: 15th Floor, Block C, Lane 58, Xinjian East Road, Minhang District, Shanghai 2. Secretary of the Board: Zhang Wei 3. Telephone: 021-54173706 4. Email: dsh2@yananpharm.com

(2) Conference fee: at your own expense

5. List of available documents
Resolutions of the 17th meeting of the second board of directors of Shanghai Yanan Pharmaceutical Yangpu Co., Ltd.

Board of Directors of Shanghai Yan'an Pharmaceutical Yangpu Co., Ltd.
August 31, 2021